SCHEMBL24536500

SCHEMBL24536500

Cc1c2ccccc2cc2[nH]ncc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METAP2 P50579 9/20 0.53
▸ IDO1 P14902 3/20 0.47
▸ HSP90AA1 P07900 1/20 0.47
▸ CDK2 P24941 1/20 0.47
▸ TRPA1 O75762 1/20 0.44
▸ PIM1 P11309 2/20 0.43
▸ PIM3 Q86V86 1/20 0.43
▸ FGFR1 P11362 1/20 0.42
▸ DYRK3 O43781 1/20 0.42
▸ CLK1 P49759 1/20 0.42
▸ CLK2 P49760 1/20 0.42
▸ CLK3 P49761 1/20 0.42
▸ GSK3B P49841 1/20 0.42
▸ CDK5 Q00535 1/20 0.42
▸ DYRK1A Q13627 1/20 0.42
▸ CDK5R1 Q15078 1/20 0.42
▸ DYRK2 Q92630 1/20 0.42
▸ CLK4 Q9HAZ1 1/20 0.42
▸ DYRK1B Q9Y463 1/20 0.42
▸ MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29680217 0.79 IDO1 (0.47) METAP2IDO1HSP90AA1CDK2PIM1
SCHEMBL31460379 0.79 IDO1 (0.47) METAP2IDO1HSP90AA1CDK2PIM1
SCHEMBL23043099 0.79 IDO1 (0.47) METAP2IDO1HSP90AA1CDK2PIM1
SCHEMBL24632431 0.78 METAP2 (0.45) METAP2IDO1HSP90AA1CDK2TRPA1
SCHEMBL29344697 0.78 METAP2 (0.45) METAP2IDO1HSP90AA1CDK2TRPA1
SCHEMBL26302437 0.78 METAP2 (0.52) METAP2IDO1HSP90AA1CDK2TRPA1
SCHEMBL10594461 0.76 METAP2 (0.53) METAP2IDO1HSP90AA1CDK2TRPA1
SCHEMBL119090 0.73 CYP1A2 (0.56) MAPK1ALDH1A1HSD17B10TDP1
SCHEMBL29360084 0.73 CYP1A2 (0.56) MAPK1ALDH1A1HSD17B10TDP1
SCHEMBL16646932 0.72 IDO1 (0.50) METAP2IDO1TRPA1FGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022227987-A1 HETEROCYCLIC DERIVATIVE AND PREPARATION METHOD THEREFOR AND USE THEREOF 浙江海正药业股份有限公司 2022-11-03 — — WO disclosed
WO-2022132200-A1 AZAQUINAZOLINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2022-06-23 — — WO disclosed
Send feedback